Variant report
Variant | nsv962386 |
---|---|
Chromosome Location | chr17:20715376-20717900 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr17:20716089-20716141 | Lung_OC | lung: | n/a | n/a |
2 | MYC | chr17:20717898-20717944 | MCF-7 | breast: | n/a | n/a |
3 | POLR2A | chr17:20717850-20717945 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr17:20715328-20718653 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ABHD17AP6 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2958458 | chr17:20715378-20715379 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs28454341 | chr17:20715390-20715391 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs536916521 | chr17:20715424-20715425 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs35425805 | chr17:20715444-20715445 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs184821922 | chr17:20715536-20715537 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs9895480 | chr17:20715574-20715575 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs557127063 | chr17:20715587-20715588 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs189407430 | chr17:20715593-20715594 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs146357765 | chr17:20715604-20715605 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs576192529 | chr17:20715645-20715646 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs544911638 | chr17:20715673-20715674 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs557098983 | chr17:20715725-20715726 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs7214373 | chr17:20715726-20715727 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560947565 | chr17:20715821-20715822 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs561901134 | chr17:20715836-20715837 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs141504154 | chr17:20715891-20715892 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs527621350 | chr17:20715915-20715916 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs565269745 | chr17:20715918-20715919 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs532614881 | chr17:20715978-20715979 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs375098932 | chr17:20715986-20715987 | Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs563037781 | chr17:20716097-20716098 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs181729238 | chr17:20716111-20716112 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs9902243 | chr17:20716177-20716178 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs142004921 | chr17:20716182-20716183 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs186999662 | chr17:20716225-20716226 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs576403058 | chr17:20716233-20716234 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs546563385 | chr17:20716291-20716292 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs9902478 | chr17:20716292-20716293 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs538702039 | chr17:20716336-20716337 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs556884308 | chr17:20716370-20716371 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs537493501 | chr17:20716383-20716384 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs199903645 | chr17:20716401-20716402 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs536032745 | chr17:20716422-20716423 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs150627355 | chr17:20716425-20716426 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs139668095 | chr17:20716426-20716427 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs540296597 | chr17:20716454-20716455 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs147475203 | chr17:20716463-20716464 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs140529989 | chr17:20716472-20716473 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs111698803 | chr17:20716473-20716474 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs189944512 | chr17:20716479-20716480 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs144443616 | chr17:20716557-20716558 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs145559002 | chr17:20716566-20716567 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs560804372 | chr17:20716567-20716568 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs527967552 | chr17:20716576-20716577 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs148914694 | chr17:20716577-20716578 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs142643572 | chr17:20716579-20716580 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs538355972 | chr17:20716590-20716591 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs550305068 | chr17:20716593-20716594 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs568599914 | chr17:20716634-20716635 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs115311603 | chr17:20716649-20716650 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20705400-20718000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr17:20715200-20715600 | Active TSS | Osteobl | bone |
3 | chr17:20715200-20715800 | Bivalent/Poised TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr17:20715200-20716000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr17:20715400-20715800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |